New developments in the basic understanding of the roles of TLR3, TLR6 and TLR7 from in vitro studies and pre-clinical models of disease may open up new avenues of TLR-targeted therapy for atherosclerosis. This evidence concerns the gene TLR6 and atherosclerosis.